FR3045605B1 - HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE - Google Patents

HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE Download PDF

Info

Publication number
FR3045605B1
FR3045605B1 FR1562500A FR1562500A FR3045605B1 FR 3045605 B1 FR3045605 B1 FR 3045605B1 FR 1562500 A FR1562500 A FR 1562500A FR 1562500 A FR1562500 A FR 1562500A FR 3045605 B1 FR3045605 B1 FR 3045605B1
Authority
FR
France
Prior art keywords
polybenzoxazine
synthesis
usable
halogenated benzoxazine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1562500A
Other languages
French (fr)
Other versions
FR3045605A1 (en
Inventor
Milan Fedurco
Marco Ribezzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michelin Recherche et Technique SA Switzerland
Compagnie Generale des Etablissements Michelin SCA
Michelin Recherche et Technique SA France
Original Assignee
Michelin Recherche et Technique SA Switzerland
Compagnie Generale des Etablissements Michelin SCA
Michelin Recherche et Technique SA France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michelin Recherche et Technique SA Switzerland, Compagnie Generale des Etablissements Michelin SCA, Michelin Recherche et Technique SA France filed Critical Michelin Recherche et Technique SA Switzerland
Priority to FR1562500A priority Critical patent/FR3045605B1/en
Publication of FR3045605A1 publication Critical patent/FR3045605A1/en
Application granted granted Critical
Publication of FR3045605B1 publication Critical patent/FR3045605B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/161,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4

Abstract

Composé benzoxazine halogénée, utilisable notamment comme monomère pour la synthèse de polybenzoxazine, répondant à la formule (A) : dans laquelle : - chaque noyau benzénique est porteur d'au moins un halogène (représenté par le symbole Hal), en particulier brome, chlore ou fluor ; - Z1 représente un groupement de liaison au moins divalent, aliphatique, cycloaliphatique ou aromatique, comportant au moins un atome de carbone et optionnellement au moins un hétéroatome choisi parmi O, S, N et P. Utilisation d'un tel composé pour la synthèse d'une polybenzoxazine, polybenzoxazine issue d'au moins un tel composé benzoxazine.Halogenated benzoxazine compound, usable in particular as a monomer for the synthesis of polybenzoxazine, corresponding to formula (A): in which: - each benzene nucleus carries at least one halogen (represented by the symbol Hal), in particular bromine, chlorine or fluorine; - Z1 represents an at least divalent, aliphatic, cycloaliphatic or aromatic bonding group, comprising at least one carbon atom and optionally at least one heteroatom chosen from O, S, N and P. Use of such a compound for the synthesis of a polybenzoxazine, polybenzoxazine derived from at least one such benzoxazine compound.

FR1562500A 2015-12-16 2015-12-16 HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE Active FR3045605B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1562500A FR3045605B1 (en) 2015-12-16 2015-12-16 HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1562500A FR3045605B1 (en) 2015-12-16 2015-12-16 HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE

Publications (2)

Publication Number Publication Date
FR3045605A1 FR3045605A1 (en) 2017-06-23
FR3045605B1 true FR3045605B1 (en) 2023-10-27

Family

ID=55646740

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1562500A Active FR3045605B1 (en) 2015-12-16 2015-12-16 HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE

Country Status (1)

Country Link
FR (1) FR3045605B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126290A (en) * 1964-03-24 Method for improving physical proper-
US7649060B2 (en) * 2005-12-02 2010-01-19 Henkel Corporation Curable compositions
JP5627196B2 (en) * 2009-04-28 2014-11-19 国立大学法人横浜国立大学 Epoxy resin composition and cured product thereof
CN104449484B (en) * 2013-09-25 2018-06-15 3M创新有限公司 Pressure sensitive adhesive, conducting resin composition and by its adhesive tape obtained and purposes
CN103936764B (en) * 2014-03-21 2016-05-04 哈尔滨工程大学 N-semiaromatic alkyl bis-phenol-diamine type four degree of functionality fluorenyl benzoxazines and preparation method thereof
CN105061464B (en) * 2015-07-30 2017-05-24 哈尔滨工程大学 Monophenol-diamine type asymmetric tri-functionality quinoxalinyl benzoxazine and preparation method thereof

Also Published As

Publication number Publication date
FR3045605A1 (en) 2017-06-23

Similar Documents

Publication Publication Date Title
MA42795B1 (en) Therapeutic compounds useful for the prophylactic or therapeutic treatment of an infection with the HIV virus
EA201891544A1 (en) INHIBITORS OF PROSTATIC SPECIFIC MEMBRANE ANTIGEN (PSMA) BASED ON URIDE FOR VISUALIZATION AND TREATMENT
PE20190711A1 (en) N- (ULFONIL FENILS) BENZAMIDS AND RELATED COMPOUNDS AS BCL-2 INHIBITORS
MA31759B1 (en) AMIDE COMPOUND
EA202091893A1 (en) NEW CRYSTALLINE FORMS
TN2019000126A1 (en) NEW ANTIVIRAL COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS-RELATED INFECTIONS.
EA201790765A1 (en) Derivatives of spirodiamine as inhibitors of aldosterone synthase
BR112015032689A2 (en) fused heterocyclic compound and pest control use thereof
CY1120477T1 (en) Receiver-actuator actuator actuated by sub-multipliers
TNSN07393A1 (en) NOVEL HISTAMINE H3 RECEPTOR LIGANDS AND THERAPEUTIC APPLICATIONS THEREOF
MX2020009234A (en) Heteroaryl compounds as type ii irak inhibitors and uses hereof.
CA2880178C (en) Difluoromethylene compound
EA201290558A1 (en) AGONISTS MGLU2
FR3079238B1 (en) CATALYTIC COMPOSITION FOR ADHESIVE COMPOSITION BASED ON CROSSLINKABLE POLYMER
CL2018002583A1 (en) Morpholine derivative
MA45782B1 (en) Modulators of the cxcr7 piperidine receptor
MD3615544T2 (en) Antitumoral compounds
EA202190272A1 (en) ADDITIONALLY SUBSTITUTED TRIAZOLOQUINOXALINE DERIVATIVES
PH12021550061A1 (en) Novel 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same
MX2022003365A (en) Single-domain antibodies directed against lilrb2.
MA39688A (en) HETEROARYL COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC DISEASES
FR3045605B1 (en) HALOGENATED BENZOXAZINE USABLE FOR THE SYNTHESIS OF POLYBENZOXAZINE
EA202190070A1 (en) BICYCLIC HISTONE DEACETYLASE INHIBITORS
BRPI0510218A (en) hot melt adhesive compositions based on olefin copolymers
BR112022018658A2 (en) METHODS TO ENHANCE THE YIELD OF RECOMBINANT ADENO-ASSOCIATED VIRUSES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20170623

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9